Concepedia

Author

Philip J. Rosenfeld

University of MiamiORCID

Also Known As

Brandon J. Lujan, D Boyer, P J Rosenfeld, P ROSENFELD, P Rosenfeld, P. J Rosenfeld, P. J. Rosenfeld, P. Rosenfeld, P.J. Rosenfeld, PHILIP J. ROSENFELD

597

Publications

38.6K

Citations

91

H-Index

141

Concepts

All Affiliations

University of MiamiUniversity of WashingtonCarl Zeiss (United States)Ophthalmology Associates (United States)Johns Hopkins University
PJ

About

Philip J. Rosenfeld is an author at University of Miami specializing in medicine, ophthalmology, and age-related diseases.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

56

90

16.3K

2

Health Sciences

18

21

1.7K

3

Engineering

9

9

444

4

Natural Sciences

9

9

2.1K

5

Law

1

1

34

Philip J. Rosenfeld

×

226

Publications

33.8K

Citations

81

H-Index

YearCitations

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier,

New England Journal of Medicine

2006

5.8K

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

Steven D. Schwartz, Carl D. Regillo, Byron L. Lam,

The Lancet

2014

1.3K

A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication

Katherine A. Jones, James T. Kadonaga, Philip J. Rosenfeld,

Cell

1987

1.1K

An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

Anne E. Fung, Geeta A. Lalwani, Philip J. Rosenfeld,

American Journal of Ophthalmology

2007

966

Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, Andrew A. Moshfeghi, Carmen A. Puliafito

Ophthalmic surgery, lasers & imaging retina

2005

902

A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

Geeta A. Lalwani, Philip J. Rosenfeld, Anne E. Fung,

American Journal of Ophthalmology

2009

882

Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT

Srinivas R. Sadda, Robyn H. Guymer, Frank G. Holz,

Ophthalmology

2017

796

Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data

Richard F. Spaide, Glenn J. Jaffe, David Sarraf,

Ophthalmology

2019

731

Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study

S. Michels, Philip J. Rosenfeld, C PULIAFITO,

Ophthalmology

2005

667

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

Anne E. Fung, Philip J. Rosenfeld, Elias Reichel

British Journal of Ophthalmology

2006

534

Page 1